Variant report
Variant | esv3401319 |
---|---|
Chromosome Location | chr5:70701746-70703744 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188374173 | chr5:70701746-70701747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535185426 | chr5:70701749-70701750 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs111450673 | chr5:70701761-70701762 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372728674 | chr5:70701775-70701776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs571906326 | chr5:70701798-70701799 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192280045 | chr5:70701806-70701807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184114977 | chr5:70701809-70701810 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375029442 | chr5:70701825-70701826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs538732642 | chr5:70701840-70701841 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546088166 | chr5:70701873-70701874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs143102226 | chr5:70701894-70701895 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544564442 | chr5:70701906-70701907 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs5005863 | chr5:70701990-70701991 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs542342264 | chr5:70701999-70702000 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187052391 | chr5:70702016-70702017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7380012 | chr5:70702050-70702051 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs191854808 | chr5:70702083-70702084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs564773609 | chr5:70702098-70702099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531915557 | chr5:70702308-70702309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114088597 | chr5:70702364-70702365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567708950 | chr5:70702446-70702447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535124778 | chr5:70702456-70702457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547067262 | chr5:70702551-70702552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565469708 | chr5:70702648-70702649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184122783 | chr5:70702693-70702694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189499429 | chr5:70702706-70702707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576236956 | chr5:70702717-70702718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs62372727 | chr5:70702820-70702821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573167347 | chr5:70702830-70702831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540468377 | chr5:70702856-70702857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182068149 | chr5:70702861-70702862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545340907 | chr5:70702961-70702962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185794650 | chr5:70703009-70703010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574865419 | chr5:70703039-70703040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565053802 | chr5:70703117-70703118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs542280664 | chr5:70703124-70703125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188873941 | chr5:70703155-70703156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543988536 | chr5:70703423-70703424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562562074 | chr5:70703424-70703425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546332347 | chr5:70703443-70703444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs200669212 | chr5:70703515-70703516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564534515 | chr5:70703533-70703534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529660603 | chr5:70703536-70703537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs376722640 | chr5:70703579-70703580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550204252 | chr5:70703583-70703584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562071660 | chr5:70703586-70703587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs540652380 | chr5:70703632-70703633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs528842017 | chr5:70703633-70703634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547002878 | chr5:70703638-70703639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565407547 | chr5:70703654-70703655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
abnormal development | 18461090 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21990379 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Apoptosis | 19488400 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Spinal muscular atrophy | 17668391 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Prostate cancer | 16461572 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:70699600-70707000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
2 | chr5:70700200-70701800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr5:70700800-70702000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr5:70700800-70702000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
5 | chr5:70700800-70702400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr5:70701200-70702400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr5:70701400-70701800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr5:70701600-70702000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr5:70701600-70702000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr5:70702000-70706800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
11 | chr5:70702000-70717400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr5:70702400-70707200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
13 | chr5:70702400-70717600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |